The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols

Clark, Andrew R.; Rachelefsky, Gary S.; Mason, P.L.; Goldenhersh, M.J.; Hollingworth, Ann

doi:10.1016/0091-6749(90)90224-r

Cited by 15 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present study confirms our earlier work and that of others into multiple dosing into spacer devices with sodium cromoglycate [5,7,8], and nedocromil sodium [9]. Multiple actuations of the MDI may decrease the amount of respirable drug recovered because of agglomeration of particles increasing their size, displacement of aerosol out of the spacer or onto the spacer walls, or the electrostatic attraction of particles to the spacer and each other.…”

Section: Discussionsupporting

confidence: 79%

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range

Barry¹,

O’Callaghan²

1994

Eur Respir J

View full text Add to dashboard Cite

We wanted to determine the amount of salbutamol available in respirable particles from the Volumatic spacer device after one, two or five actuations of a metered-dose inhaler into the spacer prior to analysis.A glass multistage liquid impinger was used to determine particle size. Aerosol was sampled after one, two or five actuations from a metered-dose inhaler into a Volumatic spacer. Each experiment was repeated four times.The amount of salbutamol recovered per actuation in particles less than 5 µm (mean and 95% confidence intervals) was: 54.3 µg (48.3-60.1) after one actuation; 42.4 µg (38.2-46.5) after two actuations, and 20.7 µg (17.5-23.9) after five actuations.We conclude that multiple actuations of salbutamol into the Volumatic spacer do not linearly increase the amount of drug available for inhalation. To maximize drug delivery, single actuations should be used prior to inhalation. In comparative studies of drugs and dosages, it must be remembered that the amount of drug delivered is not the same as that administered. Eur Respir J., 1994Respir J., , 7, 1707 by drawing an aerosol through a series of stages, each containing a glass impaction plate. Aerosol velocity increases in the device and progressively smaller particles collect at each stage. A filter after the final stage collects the smallest particles. Each stage was washed with methanol, and the amount of drug collected in each stage was assayed by high performance liquid chromatography with an ultra-violet detector at a wavelength of 276 nm.A standard MDI of salbutamol (Allen & Hanburys, 100 µg per actuation) was shaken for 10 s, connected to the MSLI and discharged into it. This was repeated 10 times to facilitate the drug assay.The experiment was repeated using the Volumatic spacer. The MDI was shaken and then actuated into the spacer. This was immediately attached to the MSLI. The spacer was positioned so that drug would not be drawn into the MSLI before attachment. To assess the effect of multiple actuations into the spacer, the MDI was actuated into the spacer one, two or five times prior to attaching it to the MSLI. For each of the experiments, the aerosol was actuated a total of 10 times. Before each actuation, the MDI was shaken for 10 s. Five new metered-dose inhalers were used. The first 10 doses from each were discarded, and the metered dose-inhaler primed by firing one shot to waste prior to each experiment.Each experiment was repeated four times, and the temperature, relative humidity and barometric pressure were recorded. The size distribution of the aerosol cloud was In the delivery of drugs to the respiratory tract, spacer devices are used to reduce the need to co-ordinate inhalation and metered-dose inhaler (MDI) actuation. Optimum spacer use improves asthma management and reduces the waste of drugs, which result from poor inhaler technique [1].Factors which affect the amount of drug obtained from spacers are not widely appreciated. Recent guidelines for the management of acute severe asthma recommend the administra...

show abstract

Section: Discussionsupporting

confidence: 79%

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range

Barry¹,

O’Callaghan²

1994

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…This is more marked for low volume spacers. 32,37,38 The various spacers vary in size from around 200 ml to 750 ml. The consensus says that (generally speaking) low volume spacers are preferable in young children, who, due to a low tidal volume, may have to use several breaths to empty a large volume spacer.…”

Section: Pmdi-spacer Combinationsmentioning

confidence: 99%

The ADMIT series — Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma

Pedersen

Dubus

Crompton³

2010

Primary Care Respiratory Journal

View full text Add to dashboard Cite

“…It should be noted that in patients requiring inhaled steroid therapy to treat their asthma, a spacer device is a recommended (if not mandatory) accessory, as it will decrease oropharyngeal impaction, thus reducing the chance of thrush. When using a spacer device, it is not recommended that multiple actuations of MDI be used per inhalation, as Clark and colleagues 9 have demonstrated a reduction in drug delivery. This is probably due to higher device retention due to turbulence inside the chamber, induced during the discharge of multiple puffs.…”

mentioning

confidence: 98%

Inhalational Therapy in Asthma

Oppenheimer

1996

allergy asthma proc

View full text Add to dashboard Cite

The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols

Cited by 15 publications

References 9 publications

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range

The ADMIT series — Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma

Inhalational Therapy in Asthma

Contact Info

Product

Resources

About